| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/27/2002 | CN1342157A Substituted pyrazoles ASP38 kinase inhibitors |
| 03/27/2002 | CN1342149A Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 03/27/2002 | CN1342145A Fused-ring compounds and use thereof as drugs |
| 03/27/2002 | CN1342074A Antidepressant heterocyclic compounds |
| 03/27/2002 | CN1341594A Substituted pyrrolidone, thiazolidone or oxazolidone as herbicide |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1081633C 1,2,4-benzothiadiazine derivatives, their preparation and use |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/27/2002 | CN1081460C Use of medicine for reducing tissue damage associated with non-cardiac ischemia by aldose reductase inhibitor |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362336 Administering a quinazoline derivative to a warm-blooded animal for producing an antiangiogenic and/or vascular permeability reducing effect |
| 03/26/2002 | US6362191 Aminometyl oxooxazolidinyl benzene derivatives |
| 03/26/2002 | US6362189 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 03/26/2002 | US6362172 Water soluble prodrugs of azole compounds |
| 03/26/2002 | US6362134 Controlling plant growth |
| 03/26/2002 | US6361764 Insoluble s-triazine derivatives and their use as UV filters |
| 03/26/2002 | CA2137953C Benzenesulfonamide derivative and process for preparing thereof |
| 03/26/2002 | CA2094703C Substituted piperazines as central nervous system agents |
| 03/21/2002 | WO2002023541A1 Zofimarin derivatives having oxazepam ring |
| 03/21/2002 | WO2002022613A1 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| 03/21/2002 | WO2002022611A2 Caspase inhibitors and uses thereof |
| 03/21/2002 | WO2002022610A1 Isoxazoles and their use as inhibitors of erk |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022602A2 Triazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022600A2 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | WO2002022599A2 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | WO2002022598A1 Quinolinone derivatives as tyrosine kinase inhibitors |
| 03/21/2002 | WO2002022595A1 N-substituted benzothiophenesulfonamide derivatives |
| 03/21/2002 | WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | WO2002022588A1 Novel pyrimidine derivative and novel pyridine derivative |
| 03/21/2002 | WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/21/2002 | WO2002022576A2 3-substituted indole carbohydrazides useful as cell proliferation and angiogenesis inhibitors |
| 03/21/2002 | WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs |
| 03/21/2002 | WO2001087846A3 Tricyclic pyrazole derivatives as protein kinase inhibitors |
| 03/21/2002 | WO2001077091A3 Ns5b hcv polymerase inhibitors |
| 03/21/2002 | WO2001077090A3 Isothiazole derivatives and their use as microbicides |
| 03/21/2002 | WO2001066099A3 Use of quinazoline derivatives as angiogenesis inhibitors |
| 03/21/2002 | WO2001014372A3 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
| 03/21/2002 | US20020035267 Tetrazolyl-phenyl acetamide glucokinase activators |
| 03/21/2002 | US20020035266 Tetrazolyl-phenyl acetamide glucokinase activators |
| 03/21/2002 | US20020035103 For diseases or conditions caused by or exacerbated by histamine-3 receptor activity |
| 03/21/2002 | US20020035102 Azetidine derivatives, their preparation and medicaments containing them |
| 03/21/2002 | US20020035094 Substituted pyridine compounds and methods of use |
| 03/21/2002 | DE10044358A1 New thiazole-5-sulfonamide derivatives useful as antiviral agents, especially for control of herpes simplex infections |
| 03/21/2002 | CA2422376A1 Isoxazoles and their use as inhibitors of erk |
| 03/21/2002 | CA2422013A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | CA2419224A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2419219A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/20/2002 | EP1188755A1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 03/20/2002 | EP1188747A1 Phenoxypropylamine compounds |
| 03/20/2002 | EP1187833A1 Method of producing nitroguanidine- and nitroenamine derivatives |
| 03/20/2002 | EP1187829A1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 03/20/2002 | EP1187827A1 Antiviral agents |
| 03/20/2002 | EP1187826A1 Heterocyclic derivatives useful as anticancer agents |
| 03/20/2002 | EP1187821A1 Benzofuranylsulfonates |
| 03/20/2002 | EP1187819A1 N-substituted perhydro diazine |
| 03/20/2002 | EP1187614A1 Substituted piperidines as melanocortin-4 receptor agonists |
| 03/20/2002 | EP1137415A4 Myt1 kinase inhibitors |
| 03/20/2002 | CN1341115A 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use |
| 03/20/2002 | CN1341114A C-21 Modified epothilones |
| 03/20/2002 | CN1341108A Polycyclic thiazole systems and their utilization as anorectics |
| 03/19/2002 | US6359151 Use as pesticides. |
| 03/19/2002 | US6359148 For polymer, lubricants; heat, oxidation resistance, photostability |
| 03/19/2002 | US6359141 1h-1,2,4-triazole compounds useful as antifungal agents |
| 03/19/2002 | US6359138 4-hydroxy-piperidine derivatives |
| 03/19/2002 | US6359134 Sulfonamide derivatives, their production and use |
| 03/19/2002 | US6358994 2-acylaminopropanamines as tachykinin receptor antagonists |
| 03/19/2002 | US6358983 Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 03/19/2002 | US6358979 N-cyclopentyl modulators of chemokine receptor activity |
| 03/19/2002 | US6358976 For therapy and prophylaxis of cancer metastasis, diabetic retinopathy, neovascular glaucoma, thrombosis, restenosis, osteoporosis, or macular degeneration |
| 03/19/2002 | US6358972 5-HT1F agonists |
| 03/19/2002 | US6358942 Microbiocides and bactericides for treating grampositive, bacteroides, clostridium, mycobacterium, staphylococcus and streptococcus infections |
| 03/19/2002 | US6358286 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 03/19/2002 | CA2173963C Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 03/14/2002 | WO2002020520A1 A thiazolidinedione derivative and its use as antidiabetic |
| 03/14/2002 | WO2002020519A1 The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 03/14/2002 | WO2002020518A1 Thiazolidinone nitrate salt |
| 03/14/2002 | WO2002020517A1 A thiazolidinedione derivative and its use as antidiabetic |
| 03/14/2002 | WO2002020515A1 Oxazolidinone antibacterial agents |
| 03/14/2002 | WO2002020512A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 03/14/2002 | WO2002020500A2 Materials and methods to potentiate cancer treatment |
| 03/14/2002 | WO2002020495A2 Inhibitors of glycogen synthase kinase 3 |
| 03/14/2002 | WO2002020489A2 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/14/2002 | WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | WO2002020484A1 Chemical compounds |
| 03/14/2002 | WO2002020483A1 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 03/14/2002 | WO2002020479A1 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 03/14/2002 | WO2002020014A1 Incompetitive inhibitors of helicase primase |
| 03/14/2002 | WO2001085760A8 Thrombin inhibitors |
| 03/14/2002 | WO2001070734A3 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 03/14/2002 | WO2001070692A3 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |